{"id":"W2613260599","doi":"10.1080/21645515.2017.1322241","title":"A new frontier in treatment of advanced melanoma: Redefining clinical management in the era of immune checkpoint inhibitors","year":2017,"lang":"en","type":"article","venue":"Human Vaccines & Immunotherapeutics","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; Impact","funders":"","keywords":"Medicine; Adverse effect; Ipilimumab; Immune checkpoint; Melanoma; Pembrolizumab; Disease; Immune system; Intensive care medicine; Oncology; Immunology; Internal medicine; Immunotherapy; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02719839,0.0005622689,0.001284029,0.001610847,0.001146044,0.004632272,0.001391276,0.003138262,0.00211534],"category_scores_gemma":[0.02534553,0.000261147,0.0007647921,0.0011416,0.004358138,0.009349144,0.002622824,0.0115369,0.001032125],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002823685,"about_ca_system_score_gemma":0.006771162,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00139743,"about_ca_topic_score_gemma":0.003842653,"domain_scores_codex":[0.9902551,0.005455848,0.001149141,0.0004676721,0.002391533,0.00028076],"domain_scores_gemma":[0.9766114,0.0110023,0.002631594,0.001105903,0.006568656,0.002080039],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003433587,0.0002906063,0.002976146,0.001792561,0.00008959378,0.0004565752,0.0007303775,0.001026792,0.002162392,0.03942927,0.1094798,0.8412225],"study_design_scores_gemma":[0.0002453188,0.001009593,0.005670507,0.009511767,0.000154381,0.002267849,0.002079317,0.00226,0.00139461,0.1154969,0.8597617,0.0001479294],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.003343628,0.3416941,0.01012801,0.6328799,0.006096933,0.00004455277,0.00005521033,0.000125016,0.005632804],"genre_scores_gemma":[0.1116924,0.6016364,0.04994046,0.177597,0.05430974,0.0001761884,0.0001667097,0.0001636874,0.004317537],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.02719839,"threshold_uncertainty_score":0.1438406,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04983230352838165,"score_gpt":0.3591291794356196,"score_spread":0.3092968759072379,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}